Abstract: A pharmaceutical composition containing macrolide, e.g. a rapamycin compound in an emulsion preconcentrate or microemulsion preconcentrate for oral administration. The carrier medium for the rapamycin compound includes a hydrophilic phase, a lipophilic phase and a surfactant. The composition is stable and provides high absorption efficiency.
Type:
Grant
Filed:
August 22, 1997
Date of Patent:
August 3, 1999
Assignee:
Novartis AG
Inventors:
Gerd Fricker, Barbara Haeberlin, Armin Meinzer, Jacky Vonderscher